| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |